NCT05814159 - A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

December 10, 2025

Study Completion Date

June 24, 2026

Conditions

Still's Disease, Juvenile OnsetStill's Disease, Adult-Onset

Interventions

DRUG

Anakinra

sub cutaneous daily injection

DRUG

Placebo

sub cutaneous daily injection

Trial Locations (8)

Fukushima Medical University Hospital, Fukushima

Hyogo Prefectural Kobe Children's Hospital, Kobe

Kobe University Hospital, Kobe

Yokohama City University Hospital (Hematology and Clinical Immunology), Yokohama

Shinshu University, Matsumoto

Tokyo Medical And Dental University Hospital, Bunkyō-Ku

Tokyo Women's Medical University Hospital, Shinjuku-Ku

Gifu University Hospital, Gifu